-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GSK-4532990 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GSK-4532990 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: ARO-HSD is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GSK-4532990 in Non-Alcoholic Steatohepatitis (NASH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GSK-4532990 in Non-Alcoholic Steatohepatitis (NASH) Drug Details: ARO-HSD is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Olpasiran in Atherosclerosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Olpasiran in Atherosclerosis Drug Details: Olpasiran (formerly known as AMG 890) is under development for...
-
Product Insights
![]()
Lion Inds FZ – DPC: Warehouse and Office Building – Dubai
Equip yourself with the essential tools needed to make informed and profitable decisions with our Lion Inds FZ - DPC: Warehouse and Office Building - Dubai report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
Scanpaper FZ – DPC: Warehouse and Office Building (6854546) – Dubai
Equip yourself with the essential tools needed to make informed and profitable decisions with our Scanpaper FZ - DPC: Warehouse and Office Building (6854546) - Dubai report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
Net Present Value Model: AROHIF-2
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model AROHIF-2 Drug Details ARO-HIF2 is under...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – ARO-HSD
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ARO-HSD Drug Details ARO-HSD is under development for the treatment of nonalcoholic steatohepatitis. The...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – olpasiran
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry olpasiran Drug Details Olpasiran (formerly known as AMG 890) is under development for the...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – AROHIF-2
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AROHIF-2 Drug Details ARO-HIF2 is under development for the treatment of clear cell renal...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.